Aug. 27 at 1:57 AM
$GBIO With funding secured through 2027, GBIO has the runway to advance clinical trials without immediate dilution, strengthening its bullish case. https://biotechhealthx.com/biotech-news/generation-bio-gbio-has-185m-in-cash-heres-why-that-matters/